Point72 Asia (Singapore)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-186,232
Closed -$341K 1025
2024
Q1
$341K Buy
+186,232
New +$341K 0.09% 251